Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China flag China · Delayed Price · Currency is CNY
23.24
+0.29 (1.26%)
Apr 30, 2026, 3:00 PM CST

SHA:605033 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
48.6636.8657.56145.09125.74
Depreciation & Amortization
32.6420.4320.8715.4712.48
Other Amortization
0.251.920.350.350.07
Asset Writedown & Restructuring Costs
20.390.030.040.120.02
Loss (Gain) From Sale of Investments
-6.32-8.23-4.58-4.04-0.91
Provision & Write-off of Bad Debts
--5.24-2.475.993.65
Other Operating Activities
-1.4319.8316.498.1913.65
Change in Accounts Receivable
16.7866.4998.49-57.22-105.49
Change in Inventory
11.7467.5985.4892.31-293.91
Change in Accounts Payable
103.2980.1567.44-71.9135.81
Operating Cash Flow
229.36280.4334.79126.41-108.75
Operating Cash Flow Growth
-18.20%-16.25%164.84%--
Capital Expenditures
-184.63-158.81-203.69-109.29-106.53
Sale of Property, Plant & Equipment
1.350.01-0.03-
Investment in Securities
-37-3888068-148
Other Investing Activities
7.889.336.516.862.61
Investing Cash Flow
-212.39-537.47-117.18-34.4-251.92
Short-Term Debt Issued
---40204.04
Long-Term Debt Issued
78732.07--
Total Debt Issued
78732.0740204.04
Short-Term Debt Repaid
----67.05-177
Long-Term Debt Repaid
-0.49-1-1.07--
Total Debt Repaid
-0.49-1-1.07-67.05-177
Net Debt Issued (Repaid)
77.51721-27.0527.04
Issuance of Common Stock
---25.57391.84
Repurchase of Common Stock
---25.91--
Common Dividends Paid
-24.09-28.24-29.82-26.67-3.29
Other Financing Activities
-24.1-18.91-3.6869.99-65
Financing Cash Flow
29.3224.85-58.4241.84350.59
Foreign Exchange Rate Adjustments
-0---0.06
Net Cash Flow
46.28-232.22159.2133.85-10.02
Free Cash Flow
44.74121.59131.117.12-215.28
Free Cash Flow Growth
-63.21%-7.26%665.68%--
Free Cash Flow Margin
4.91%13.73%18.75%1.89%-25.55%
Free Cash Flow Per Share
0.330.890.980.13-1.95
Cash Income Tax Paid
3.7913.3315.8526.3619.05
Levered Free Cash Flow
11.06180.84132.4-48.62-303.49
Unlevered Free Cash Flow
11.06180.85132.64-48-301.43
Change in Working Capital
135.15214.79246.54-44.75-263.45
Source: S&P Global Market Intelligence. Standard template. Financial Sources.